Emerge Biotech strives to advance the quality of antibodies by delivering antibodies with guaranteed specificity.
Emerge Biotech is a technology-driven and innovative startup based at the Stevenage Bioscience Catalyst, an Open Innovation Biotechnology Center in North London.
Emerge Biotech uses an advanced and cost-effective platform for the validation of antibody specificity using RNA interference technology.
The company is instrumental in improving product quality in the research antibody market and strives to support the diagnostics and therapeutics market. Whilst bringing novel antibodies to the market, Emerge Biotech is partnering with the antibody industry on a national and international level to advance future diagnostics and medicines.